Zobrazeno 1 - 10
of 412
pro vyhledávání: '"MARCO LUCCHI"'
Autor:
Luca Bertolaccini, Oriana CIani, Marco Lucchi, Francesco Zaraca, Alessandro Bertani, Roberto Crisci, Lorenzo Spaggiari
Publikováno v:
JMIR Research Protocols, Vol 13, p e67629 (2024)
Externí odkaz:
https://doaj.org/article/15c1bf2a5b3d44e1a1a0665126ef61a7
Autor:
Luca Bertolaccini, Oriana Ciani, Marco Lucchi, Francesco Zaraca, Alessandro Bertani, Roberto Crisci, Lorenzo Spaggiari
Publikováno v:
JMIR Research Protocols, Vol 13, p e57183 (2024)
BackgroundLung cancer, predominantly non-small cell lung cancer (NSCLC), remains a formidable challenge, necessitating an in-depth understanding of evolving treatment paradigms. The Italian Lung Cancer Observational Study (LUCENT) addresses this need
Externí odkaz:
https://doaj.org/article/4b8b7747673c48419e1cfaed306cf430
Autor:
Roberto Silvestri, Filomena Rea, Marianna Vitiello, Gabriele Moretti, Vittorio Aprile, Marco Lucchi, Paolo Aretini, Chiara Maria Mazzanti, Stefano Landi, Federica Gemignani
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e32152- (2024)
Objectives: This study aims to determine whether the sequencing of DNA extracted from pleural fluids (PFs) of Pleural Mesothelioma (PM) patients accurately represents the genetic information obtained from the solid tissue counterpart biopsies with pa
Externí odkaz:
https://doaj.org/article/4e2a57cd4d2047b8b378ebb94f5af9b0
Autor:
Eleonora Pardini, Federico Cucchiara, Sara Palumbo, Giulia Tarrini, Alessia Di Vita, Fabio Coppedè, Vanessa Nicolì, Melania Guida, Michelangelo Maestri, Roberta Ricciardi, Vittorio Aprile, Marcello C. Ambrogi, Serena Barachini, Marco Lucchi, Iacopo Petrini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThymic epithelial tumors are rare malignant neoplasms that are frequently associated with paraneoplastic syndromes, especially myasthenia gravis. GTF2I is an oncogene mutated in a subgroup of thymomas that is reputed to drive their growth.
Externí odkaz:
https://doaj.org/article/1317aeb6d08d463381873c513bc9a53d
Autor:
Iosè Di Stefano, Greta Alì, Anello Marcello Poma, Rossella Bruno, Agnese Proietti, Cristina Niccoli, Carmelina Cristina Zirafa, Franca Melfi, Maria Giovanna Mastromarino, Marco Lucchi, Gabriella Fontanini
Publikováno v:
Diagnostics, Vol 13, Iss 18, p 2945 (2023)
Pleural mesothelioma (PM) comprises three main subtypes: epithelioid, biphasic and sarcomatoid, which have different impacts on prognosis and treatment definition. However, PM subtyping can be complex given the inter- and intra-tumour morphological h
Externí odkaz:
https://doaj.org/article/2946ea5f228745a8956b5b11e79a0790
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/ad61641da4cd438091ee423d36d8b30e
Autor:
Elisa Sicolo, Maria Giovanna Mastromarino, Giacomo Rabazzi, Diana Bacchin, Greta Ali, Vittorio Aprile, Marco Lucchi
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
Primary pulmonary leiomyosarcomas (PPLs) are incredibly rare tumors, characterized by an often-aggressive clinical behavior. Diagnosis is frequently incidental. Whenever present, symptoms are nonspecific, thus PPLs are usually misdiagnosed as other m
Externí odkaz:
https://doaj.org/article/62001a762c4c49b986312a3ecbd97b9f
Autor:
Greta Alì, Iosè Di Stefano, Anello Marcello Poma, Stefano Ricci, Agnese Proietti, Federico Davini, Marco Lucchi, Franca Melfi, Gabriella Fontanini
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Delta-like protein 3 (DLL3) is a protein of the Notch pathway, and it is a potential therapeutic target for high-grade lung neuroendocrine tumors (NETs), i.e., small cell lung carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC). However,
Externí odkaz:
https://doaj.org/article/1e4f31b17ff544ffac8df3430ffcd70d
Autor:
Maria Giovanna Mastromarino, Alessandra Lenzini, Vittorio Aprile, Greta Alì, Diana Bacchin, Stylianos Korasidis, Marcello Carlo Ambrogi, Marco Lucchi
Publikováno v:
Diagnostics, Vol 12, Iss 12, p 2905 (2022)
The 2021 WHO Classification of Tumors of the Pleura has introduced significant changes in mesothelioma codification beyond the three current histological subtypes—epithelioid, sarcomatoid and biphasic. Major advances since the 2015 WHO classificati
Externí odkaz:
https://doaj.org/article/8d42addd11c14c35844a3ad6bfdf6fd2
Autor:
Rossella Bruno, Anello Marcello Poma, Greta Alì, Claudia Distefano, Agnese Proietti, Antonio Chella, Marco Lucchi, Franca Melfi, Renato Franco, Gabriella Fontanini
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 674 (2022)
Biphasic is the second most common histotype of pleural mesothelioma (PM). It shares epithelioid and sarcomatoid features and is challenging to diagnose. The aim of this study was to identify biphasic PM markers to improve subtyping and prognosis def
Externí odkaz:
https://doaj.org/article/6e72381c8d2244398b45489d4d9fba45